Researchers from Southern Cross University (SCU), in partnership with the Melbourne Integrative Oncology Group (MIOG), are launching an Australian-first clinical study investigating whether hyperbaric oxygen therapy (HBOT) can safely support patients undergoing treatment for high-grade glioma brain cancer. Backed by a $1 million gift from an anonymous donor, the collaborative research will examine whether delivering oxygen in a pressurised environment during active cancer treatment
2026 Copyright © News-Matic.com. All Rights Reserved
